Biometric firm that targets drunk workers secures $2.1 million
TruTouch technologies recently secured an additional $2.1 million in venture capital funding after its initial ten year $60 million investment; the company sells non-invasive alcohol intoxication detection devices that use infrared light; its technology is primarily aimed at preventing workplace injuries and detecting drunk drivers, but is also applied to diagnostic medicine; TruTouch has also recently inked a deal with Takata Corp. to install its devices in cars; the device would measure a driver’s alcohol level and if they are over the limit ignition is blocked
TruTouch Technologies, Inc., a firm that offers biometric solutions to detect alcohol intoxication levels, has just secured $2.1 million in additional funding and a major new partnership.
The company’s device uses a non-invasive infrared scanner that measures light instead of existing alcohol tests that rely on breathalyzers, blood tests, or urine samples. The system can be operated with minimal supervision as devices can be configured to automatically generate and transmit results.
After an initial ten year $60 million investment, TruTouch has secured another $2.1 million in funding from venture capitalists.
With its technology, TruTouch hopes to “render obsolete harmful alcohol-impaired activity in virtually all its public forms, from workplace accidents to illicit alcohol sales to drunk driving.”
TruTouch has also just announced a partnership with Takata Corp. to install its device in automobiles to create the next generation of alcohol detection systems for car manufacturers. Using a small sensor to measure alcohol levels, the ignition will be blocked if the driver is above the legal limit.
Dave Durgin, a general partner with Verge Fund, a TruTouch investor, says the technology has been tested and is ready to be installed in vehicles.
“We’ve already demonstrated the feasibility of putting the technology into automobiles,” and “under phase II, we’ll actually put it into an automobile in partnership with Takata,” he said.
He hopes to “demonstrate it in an actual vehicle within 12 to 18 months.”
p
In a statement Dr. Richard D Gill, president and CEO of TruTouch,said, “We are delighted to announce this partnership, which recognizes our commitment to reducing the devastating costs caused by alcohol-related accidents and injuries.”
TruTouch has been primarily used for law enforcement and work place safety, but the company is looking to expand its use in diagnostic medicine.
TruTouch is based in Albuquerque, New Mexico and Farmington, Massachusetts.